Support for trials of promising medications through the Pharmaceutical Benefits Scheme.
作者信息
Flecknoe-Brown S C
出版信息
Med J Aust. 1995 Apr 17;162(8):447. doi: 10.5694/j.1326-5377.1995.tb139995.x.
Abstract
摘要
相似文献
1
Support for trials of promising medications through the Pharmaceutical Benefits Scheme.通过药品福利计划支持对有前景药物的试验。
Med J Aust. 1995 Apr 17;162(8):447. doi: 10.5694/j.1326-5377.1995.tb139995.x.
2
Support for trials of promising medications through the Pharmaceutical Benefits Scheme.通过药品福利计划支持有前景药物的试验。
Med J Aust. 1995 Apr 17;162(8):447; author reply 447-8. doi: 10.5694/j.1326-5377.1995.tb138409.x.
3
4
More Chinese get free drugs in clinical trials.更多中国人在临床试验中获得免费药物。
Wall St J (East Ed). 2006 Feb 14:B1, B8.
5
Estimating the cost of new drug development: is it really 802 million dollars?估算新药研发成本：真的是8.02亿美元吗？
Health Aff (Millwood). 2006 Mar-Apr;25(2):420-8. doi: 10.1377/hlthaff.25.2.420.
6
Sources of bias in the economic analysis of new drugs.新药经济分析中的偏倚来源。
JAMA. 2000 Mar 15;283(11):1424.
7
Sources of bias in the economic analysis of new drugs.新药经济分析中的偏倚来源。
JAMA. 2000 Mar 15;283(11):1423-4.
8
Sources of bias in the economic analysis of new drugs.新药经济分析中的偏倚来源。
JAMA. 2000 Mar 15;283(11):1424.
9
Editor's note: Industry support of articles published in Mayo Clinic Proceedings.编者按：梅奥诊所学报发表文章的行业支持情况。
Mayo Clin Proc. 2006 Jun;81(6):851-2. doi: 10.4065/81.6.851.
10
Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research.药物研发中的规模与范围：剖析制药研究中规模的优势
J Health Econ. 2001 Nov;20(6):1033-57. doi: 10.1016/s0167-6296(01)00108-4.
Zotero 插件